In a move that may upset the Trump administration, California-based chip maker GlobalFoundries has announced that it plans to build a new fabrication plant in China at a cost of $10 billion.
The move is part of an expansion strategy that will include increasing production of its semiconductors in facilities in the U.S., Germany, and Singapore. But the U.S. facilities are likely to see the most modest growth.
The new Chinese plant, which will be built in the city of Chengdu, is quite another story. It’s expected to produce up to 85,000 silicon wafers per month by the end of 2019, according to AnandTech, making it one of the company’s highest-capacity plants.
The New York Times suggests that Chinese government initiatives are to thank for the new plant. Heavy investment in the semiconductor industry and new initiatives that encourage domestic companies to use chips built inside Chinese borders mean that it’s a good time to set up shop in China.
Several Asian tech firms have recently stated that they plan to set up manufacturing operations in the U.S. in the coming years. In another article, though, the Times suggests that CEOs of Chinese companies may have taken a cue from Trump’s style of business: make big promises, even if they’re unlikely to come to full fruition.
The GlobalFoundries news serves as a reminder that whatever Trump may say, the East still exerts a powerful appeal. It’s understandable: there’s a talented workforce, reasonably priced labor, and a healthy market to boot.
The White House knows that this is a problem. Late last year, the Obama administration put together a new task force of industry experts in a bid to help home-grown semiconductor companies battle overseas challengers and expand their fabrication operations in the U.S. But there’s still, clearly, a way to go.
(Read more: AnandTech, New York Times, “China’s Bid to Dominate the Chip Industry Is in Danger of Falling Short,” “Made in America: Asian Tech Giants Say They Will Expand U.S. Operations Under Trump,” “Can the White House Make America’s Chip Industry Great Again?”)
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
The baby formula shortage has birthed a shady online marketplace
Desperate parents just want to feed their babies. They’re having to contend with misinformation, price gouging, and scams along the way.
I tried to buy an Olive Garden NFT. All I got was heartburn.
Our newest issue spells out what you need to know about the dizzying world of digital money.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.